Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G. +4 more·2015·Nature Communications
DOI 10.1038/ncomms8458

Cited by (512)

Items 201–300 of 512

  1. EZH2 as a mediator of treatment resistance in melanoma
    Jessamy C. Tiffen, Stuart J. Gallagher, Hsin‐Yi Tseng, Fabian V. Filipp, Barbara Fazekas de St Groth, Peter Hersey · 2016 · Pigment Cell & Melanoma Research
  2. Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice
    Jonathan S. Fletcher, Jianqiang Wu, Walter J. Jessen, Jay Pundavela, Jacob A. Miller, Eva Dombi, Mi‐Ok Kim, Tilat A. Rizvi, Kashish Chetal, Nathan Salomonis et al. · 2019 · JCI Insight
  3. Epigenetic mechanisms of tumor resistance to immunotherapy
    Arenas-Ramirez, Natalia, Sahin, Dilara, Boyman, Onur · 2018 · Cellular and Molecular Life Sciences
  4. T Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-Positioning
    Alison E. Gaylo, Dillon C. Schrock, Ninoshka R.J. Fernandes, Deborah J. Fowell · 2016 · Frontiers in Immunology
  5. Immune-Suppressing Cellular Elements of the Tumor Microenvironment
    Douglas T. Fearon · 2016 · Annual Review of Cancer Biology
  6. Endosomal toll‐like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus
    Marwah M. Albakri, Frank A. Veliz, Steven Fiering, Nicole F. Steinmetz, Scott F. Sieg · 2019 · Immunology
  7. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration
    Jing Jin, Qijie Zhao · 2020 · Theranostics
  8. Defining Immunogenic and Radioimmunogenic Tumors
    Terry R. Medler, Tiffany C. Blair, Marka R. Crittenden, Michael J. Gough · 2021 · Frontiers in Oncology
  9. TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer
    Yaping Chen, Hao Huang, Yuan Li, Wenlu Xiao, Yingting Liu, Rongzhang Chen, Yulan Zhu, Xiao Wei Zheng, Changping Wu, Lujun Chen · 2022 · Frontiers in Immunology
  10. Immune Cell Migration to Cancer
    Allison T. Ryan, Minsoo Kim, Kihong Lim · 2024 · Cells
  11. Infiltration characteristics and regulatory mechanisms of CD8+ T lymphocytes in solid tumors: spatial distribution, biological functions, and interactions with the immune microenvironment
    Peng Ouyang, Jianhong Zhang, Xiao He, Congcong Yang, Dingcheng Zeng, Daofeng Xu · 2025 · Frontiers in Immunology
  12. Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma
    Jossie Rotman, Anne Marijne Heeren, Awa A. Gassama, Sinéad M. Lougheed, Noëlle Pocorni, Anita G.M. Stam, Maaike C.G. Bleeker, Henry J.M.A.A. Zijlmans, Constantijne Helene Mom, Gemma G. Kenter et al. · 2020 · Clinical Cancer Research
  13. ACKR4 restrains antitumor immunity by regulating CCL21
    Carly E. Whyte, Maleika Osman, Ervin E. Kara, Caitlin A. Abbott, Jade Foeng, Duncan R. McKenzie, Kevin Aaron Fenix, Yuka Harata‐Lee, Kerrie L. Foyle, Sarah Theresa Boyle et al. · 2020 · The Journal of Experimental Medicine
  14. Investigating T Cell Immunity in Cancer: Achievements and Prospects
    Zhen Zeng, Hui Yi Chew, Jazmina L. Gonzalez Cruz, Graham Robert Leggatt, James W. Wells · 2021 · International Journal of Molecular Sciences
  15. Engineering CAR T cells for enhanced efficacy and safety
    Yiqian Wu, Ziliang Huang, Reed E. S. Harrison, Longwei Liu, Linshan Zhu, Yinglin Situ, Yingxiao Wang · 2022 · APL Bioengineering
  16. Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma
    Katarina Pinjušić, Olivier Dubey, Olga Egorova, Sina Nassiri, Etienne Meylan, Julien Faget, Daniel B. Constam · 2022 · Journal for ImmunoTherapy of Cancer
  17. Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors
    Gang Xin, David Schauder, Weiqing Jing, Aimin Jiang, Nikhil S. Joshi, Bryon D. Johnson, Weiguo Cui · 2017 · Proceedings of the National Academy of Sciences
  18. The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
    Daniela Lulli, Maria Luigia Carbone, Saveria Pastore · 2017 · International Journal of Molecular Sciences
  19. The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
    S. Aghamiri, Rada Amin · 2025 · Current Issues in Molecular Biology
  20. ACTIVE IMMUNOTHERAPY FOR CANCER
    M. R. Schinitsky · 1973 · The Lancet
  21. Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
    Laura Evgin, Richard G. Vile · 2021 · Cancers
  22. Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma
    Rosa Nguyen, Xiyuan Zhang, Ming Sun, Shahroze Abbas, Charlie Seibert, Michael C. Kelly, Jack F. Shern, Carol J. Thiele · 2022 · Clinical Cancer Research
  23. CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases
    Kiah L. Butler, Eleanor Clancy‐Thompson, David W. Mullins · 2017 · Scientific Reports
  24. The Complexity of Targeting Chemokines to Promote a Tumor Immune Response
    Marianne Strazza, Adam Mor · 2020 · Inflammation
  25. Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
    Nicolas Jacquelot, Jonathan M. Pitt, David Pierre Enot, María Paula Roberti, Connie P.M. Duong, Sylvie Rusakiewicz, Alexander M.M. Eggermont, Laurence Zitvogel · 2017 · OncoImmunology
  26. Mutations in the notch signalling pathway are associated with enhanced anti‐tumour immunity in colorectal cancer
    Fei Wang, Jie Long, Liang Li, Zhibin Zhao, Wei Fang, Yuan Yao, Wenjing Qiu, Zixin Wu, Qing‐Qing Luo, Wei Liu et al. · 2020 · Journal of Cellular and Molecular Medicine
  27. Perspectives on the Biological Role of Chemokine:Glycosaminoglycan Interactions
    Tracy M. Handel, Douglas P. Dyer · 2020 · Journal of Histochemistry & Cytochemistry
  28. Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
    Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2021 · Cancer Immunology Research
  29. RNAi-based modulation of IFN-γ signaling in skin
    Qi Tang, Jacquelyn Sousa, Dimas Echeverria, Xueli Fan, Ying-Chao Hsueh, Khashayar Afshari, Nicholas MeHugh, David Cooper, Lorenc Vangjeli, Kathryn R. Monopoli et al. · 2022 · Molecular Therapy
  30. New pairings and deorphanization among the atypical chemokine receptor family — physiological and clinical relevance
    Martyna Szpakowska, Giulia D’Uonnolo, Rafael Luís, Ana Alonso Bartolomé, Marcus Thelen, Daniel F. Legler, Andy Chevigné · 2023 · Frontiers in Immunology
  31. Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
    Manja Idorn, Per thor Straten · 2018 · Cells
  32. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity
    Hua Zhong, Wen Lu, Yong Tang, Clotilde Wiel, Yong Wei, Jian Ping Cao, Gregory Riedlinger, Thales Y. Papagiannakopoulos, Jessie Yanxiang Guo, Martin O. Bergö et al. · 2023 · Oncogene
  33. CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells
    Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Ryutaro Kajihara, Kristopher M. Attwood, Xuefang Cao, Fumito Ito · 2021 · Cancer Immunology Immunotherapy
  34. Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
    James McAuliffe, Hok Fung Chan, Laurine Noblecourt, Ramiro A. Ramirez-Valdez, Vinnycius Pereira Almeida, Yaxuan Zhou, Emily Pollock, Federica Cappuccini, Irina Redchenko, Adrian V. S. Hill et al. · 2021 · Journal for ImmunoTherapy of Cancer
  35. Epigenetics of Dendritic Cells in Tumor Immunology
    Gerard Godoy‐Tena, Esteban Ballestar · 2022 · Cancers
  36. Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?
    Lih Yin Tan, Carmela Martini, Zvi Gregorio Fridlender, Claudine S. Bonder, Michael Paul Brown, Lisa M. Ebert · 2017 · Clinical & Translational Immunology
  37. Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response
    Thorsten R. Mempel, Francesco Marangoni · 2019 · Immunological Reviews
  38. Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review
    Yamei Chen, Ying Jin, Xiao Hu, Ming Chen · 2022 · Journal of Cancer Research and Clinical Oncology
  39. Coengineering specificity, safety, and function into T cells for cancer immunotherapy
    Greta Maria Paola Giordano Attianese, Sarah Ash, Melita B. Irving · 2023 · Immunological Reviews
  40. Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
    Mei Zhang, Liane Chun, Víctor Sandoval, Hallie J. Graor, Jay Myers, Joseph M. Nthale, Peter Rauhe, Zachary J. Senders, Kevin C. Choong, Alex Yee-Chen Huang et al. · 2017 · OncoImmunology
  41. Anti-CTLA-4 antibody self-presented dendritic cell nanovesicles boost the immunotherapy of hepatocellular carcinoma after microwave ablation
    Tan Li, Bo Li, Liteng Lin, Gengjia Chen, Xiaobin Wang, Ye Chen, Wensou Huang, Mingyue Cai, Xintao Shuai, Kangshun Zhu · 2024 · Journal of Controlled Release
  42. The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development
    Danielle Benedict Sacdalan, Josephine Anne Lucero · 2021 · OncoTargets and Therapy
  43. TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cells
    Yuxiang Tang, Weiqi Yao, Hang Hu, Wei Xiong, Heng Mei, Yu Hu · 2023 · Materials Today Bio
  44. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APCmin/+ mice
    Paulina Akéus, Louis Szeponik, Filip Ahlmanner, Patrik Sundström, Samuel Alsén, Bengt G. Gustavsson, Tim D. Sparwasser, Sukanya Raghavan, Marianne Quiding‐Järbrink · 2018 · Cancer Immunology Immunotherapy
  45. In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
    Fumito Ito, Trupti D. Vardam, Michelle M. Appenheimer, Kevin Hasegawa Eng, Sandra O. Gollnick, Jason B. Muhitch, Sharon S. Evans · 2019 · International Journal of Hyperthermia
  46. The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?
    Joseph Mounir Obeid, Yinin Hu, Gulsun Erdag, Katie M. Leick, Craig Lee Slingluff · 2017 · Melanoma Research
  47. Homeostatic Cytokines Drive Epigenetic Reprogramming of Activated T Cells into a “Naive-Memory” Phenotype
    Guido Frumento, Kriti Verma, Wayne D. Croft, Andrea J. White, Jianmin Zuo, Zsuzsanna Nagy, Stephen Kissane, Graham Anderson, Paul A. H. Moss, Frederick E. Chen · 2020 · iScience
  48. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma
    Pengcheng Wang, Zhiqiang Hu, Shao‐Lai Zhou, Songyang Yu, Li Mao, Sheng Su, Lee Jia, Ning Ren, Xiaowu Huang · 2021 · Cancer Science
  49. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes
    Lih Y. Tan, Michaelia P. Cockshell, Eli Moore, Kay K. Myo Min, Michael Ortiz, M. Zahied Johan, Brenton Ebert, Andrew Ruszkiewicz, Michael Paul Brown, Lisa M. Ebert et al. · 2022 · OncoImmunology
  50. Application of adoptive cell therapy in hepatocellular carcinoma
    Dengqiang Wu, Yujie Li · 2023 · Immunology
  51. PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
    Noor Abdala-Saleh, Jennie Lugassy, Akshatha Shivakumar-Kalvhati, Abeer Turky, Sari Abu Ras, Hila Razon, Nir Berger, Dana Bar-On, Yotam Bar‐On, Tetsuya Taura et al. · 2024 · Frontiers in Immunology
  52. Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer
    Fangfang Chen, Jingping Yuan, Honglin Yan, Huan Liu, Shuai Yin · 2019 · BioMed Research International
  53. Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer
    Xiaobao Yang, Jinrong Lin, Guanzheng Wang, Dakang Xu · 2022 · Cancers
  54. PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
    Bing-Syuan Chung, I‐Chuang Liao, Peng‐Chan Lin, Shang‐Yin Wu, Jui‐Wen Kang, Bo‐Wen Lin, Po-Chuan Chen, Ren‐Hao Chan, Chung‐Ta Lee, Meng-Ru Shen et al. · 2022 · International Journal of Molecular Sciences
  55. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma
    Yiyang Yu, Hongliang Zhang, Tingting Ren, Yi Huang, Xin Liang, Wei Wang, Jianfang Niu, Yu Han, Wei Guo · 2020 · Journal of Cellular and Molecular Medicine
  56. Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy
    Eihab Abdelfatah, Mark D. Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher M. Attwood, Junko Matsuzaki, Brahm H. Segal et al. · 2023 · Cancer Research Communications
  57. Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression In Vivo
    Richard J. Beck, Maarten Slagter, Joost B. Beltman · 2019 · Cancer Research
  58. Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment
    Osama A. A. Madkhali, Sivakumar S. Moni, Yosif Almoshari, Fahad Y. Sabei, Awaji Y. Safhi · 2025 · Cancer Biology & Therapy
  59. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
    Federica Gaiani, Federica Marchesi, Francesca Negri, Luana Greco, Alberto Malesci, Gian Luigi de’Angelis, Luigi Laghi · 2021 · International Journal of Molecular Sciences
  60. Mechanistic rationales for combining immunotherapy with radiotherapy
    Alexander Chi, Nam Phong Nguyen · 2023 · Frontiers in Immunology
  61. Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
    Elisa C. Toffoli, Abdolkarim Sheikhi, Roeland Lameris, Lisa A. King, Amanda A. van Vliet, Bruce K. Walcheck, Henk M.W. Verheul, Jan Spanholtz, Jurriaan B. Tuynman, Tanja D. de Gruijl et al. · 2021 · Cancers
  62. Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors
    Dae Joong Kim, Swetha Anandh, Jamie L. Null, Piotr Przanowski, Sanchita Bhatnagar, Pankaj Kumar, Sarah E. Shelton, Erin E. Grundy, Katherine Bakshian Chiappinelli, Roger Dale Kamm et al. · 2023 · Nature Communications
  63. The role of NK cell as central communicators in cancer immunity
    Tobias Bald, Anna‐Marie Pedde, Dillon Corvino, Jan P. Böttcher · 2020 · Advances in immunology
  64. Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties
    Natalija Budimir, Joseph S. Dolina, Jie Wei, Xiao Wang, Shih-Hsun Chen, Pamela Santiago, Guanghuan Tu, Luca Micci, Amir A. Al-Khami, Sophia X. Pfister et al. · 2021 · Journal for ImmunoTherapy of Cancer
  65. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
    Shailendra Kumar Maurya, Parvez Κhan, Asad Ur Rehman, Ranjana Kumari Kanchan, Naveenkumar Perumal, Sidharth Mahapatra, Hitendra Singh Chand, Juan A. Santamaria‐Barria, Surinder K. Batra, Mohd Wasim Nasser · 2021 · Seminars in Cancer Biology
  66. Migratory Engineering of T Cells for Cancer Therapy
    Stefanos Michaelides, Hannah Obeck, Daryna Kechur, Stefan Endres, Sebastian Kobold · 2022 · Vaccines
  67. Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
    Jensen W. Abascal, Michael S. Oh, Elvira L. Liclican, Steven M. Dubinett, Ramin Salehi‐Rad, Bin Liu · 2023 · Cells
  68. TGF-β in tumor development and progression: mechanisms and therapeutics
    Jialing Liu, Yiwei Wang, Chao Tang, L. Zhang, Sidong Xiong, Jun Wang, Chunsheng Dong · 2026 · Molecular Biomedicine
  69. Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
    Jack Y. Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, Mia Han, Jun Zhang, Ravindra Gujar, Jon V. Salazar, Reneta Hermiz, Lauren Svenson, Erica Browning et al. · 2022 · Molecular Therapy — Oncolytics
  70. Delivery of CXCL9/10/11 plasmid DNAs promotes the tumor-infiltration of T cells and synergizes with PD1 antibody for treating lung cancer
    Yuxia Ma, Yi Liu, Ying Zhi, Haibin Wang, Mei Yang, Jieting Niu, Li Zhao, Pengsheng Wang · 2022 · Cancer Nanotechnology
  71. Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma
    Nadine L. Ammann, Yasmin F. Schwietzer, Christian Meß, Julia-Christina Stadler, Glenn Geidel, Julian Kött, Klaus Pantel, Stefan W. Schneider, Jochen Sven Utikal, Alexander Thomas Bauer et al. · 2022 · Cancers
  72. The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
    Anita L. Kalluri, Pavan P. Shah, Michael K. Lim · 2023 · International Journal of Molecular Sciences
  73. A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin
    Fanny Lafouresse, Joanna R. Groom · 2018 · Frontiers in Immunology
  74. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
    Vasiliki Koliaraki, Ana Raquel Henriques, Alejandro Prados, George A. Kollias · 2020 · The Journal of Experimental Medicine
  75. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine
    Qian Cao, Randall Tyler Mertens, Kisha Nandini Sivanathan, Xuechun Cai, Peng Xiao · 2022 · Journal of Leukocyte Biology
  76. Chemokine Receptor Expression on T Cells Is Modulated by CAFs and Chemokines Affect the Spatial Distribution of T Cells in Pancreatic Tumors
    Laia Gorchs, Marlies Oosthoek, Tülay Yucel‐Lindberg, Carlos Fernández Moro, Helen Kaipe · 2022 · Cancers
  77. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance
    Mark Owyong, Niloufar Hosseini-Nassab, Gizem Efe, Alexander T. Honkala, Renske J.E. van den Bijgaart, Vicki Plaks, Bryan Ronain Smith · 2017 · Drug Resistance Updates
  78. Activation of human vascular endothelium in melanoma metastases induces ICAM ‐1 and E‐selectin expression and results in increased infiltration with effector lymphocytes
    Carsten Weishaupt, Meike Steinert, Georg Brunner, Hans‐Joachim Schulze, Robert C. Fuhlbrigge, Tobias Goerge, Karin Loser · 2019 · Experimental Dermatology
  79. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells
    Sandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, Gautam V. Sondarva, Rakesh Sathish Nair, Periannan Sethupathi, Matthew J. Dorman, Subhash C. Sinha, Kent F. Hoskins, Gregory R. J. Thatcher et al. · 2020 · Journal for ImmunoTherapy of Cancer
  80. New cytometry tools for immune monitoring during cancer immunotherapy
    Shomyseh Sanjabi, Sean P. Lear · 2021 · Cytometry Part B Clinical Cytometry
  81. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma
    Yishuai Li, Longyu Zhu, Ran Hao, Yuejun Li, Qinfei Zhao, Shujun Li · 2021 · Journal of Cellular and Molecular Medicine
  82. The dual role of CXCL9/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma
    Yu Fen Gu, Zhihui Zhang, Hao Huang, Wenyong Zhu, Hongjia Liu, Rongxin Zhang, Nan Ping Weng, Xiao Song Sun · 2025 · Frontiers in Immunology
  83. Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
    Tomoyoshi Inoue, Thomas Byrne, Mitsuko Inoue, Madeline Tait, Patrick Wall, Annabel Wang, Michael R. Dermyer, Hanane Laklai, Joseph J. Binder, Clare Lees et al. · 2021 · Molecular Cancer Therapeutics
  84. Microwave ablation combined with PD‐L1 blockade synergistically promotes Cxcl9‐mediated antitumor immunity
    Ningning He, Hao Huang, Shaoxian Wu, Weipeng Ji, Yicheng Tai, Ruicheng Gao, Yingting Liu, Yungang Liu, Lujun Chen, Dawei Zhu et al. · 2024 · Cancer Science
  85. Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease
    M. Merle, Dorothea Fischbacher, Anja Liepert, Christine Grabrucker, Tanja Kroell, Andreas Kremser, Julia Dreyßig, Markus Freudenreich, Friedhelm R. Schuster, Arndt Borkhardt et al. · 2019 · Immunological Investigations
  86. Dendritic Cells in the Tumor Microenvironment
    Karan Kohli, Venu Gopal Pillarisetty · 2020 · Advances in experimental medicine and biology
  87. Spatial determinates of effector and memory CD8+ T cell fates*
    Brigette C. Duckworth, Raymond Z. Qin, Joanna R. Groom · 2021 · Immunological Reviews
  88. Impact of tumor microenvironment on adoptive T cell transfer activity
    Celia Martín-Otal, Flor C. Navarro, Noëlia Casares, Aritz Lasarte-Cía, Inés Sánchez-Moreno, Sandra Hervás‐Stubbs, Teresa Lozano, Juan José Lasarte · 2022 · International review of cytology
  89. Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma
    Lu Liu, Jinlan Gao, Xuesha Xing, Meixi Jiang, Qi Liu, Shusen Wang, Yang Luo · 2022 · Journal of Experimental & Clinical Cancer Research
  90. Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer
    Thinle Chodon, Amit Anand Lugade, Sebastiano Battaglia, Kunle O. Odunsi · 2018 · Hematology/Oncology Clinics of North America
  91. Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment
    Juanjuan Wang, Yi Shi, Yunhuan Gao, Ningning Zhu, Yuqing Liu, Yuan Zhang, Xu Chen, Rongcun Yang · 2026 · Journal for ImmunoTherapy of Cancer
  92. Metabolism of Immune Cells in the Tumor Microenvironment
    Jin Gyoung Jung, Anne Le · 2021 · Advances in experimental medicine and biology
  93. Increased IL-6 expression precedes reliable viral detection in the rhesus macaque brain during acute SIV infection
    Raja Mohan Gopalakrishnan, Malika Aïd, Noe B. Mercado, Caitlin Davis, Shaily Malik, Emma Geiger, Valerie Varner, Rhianna A. Jones, Steven E. Bosinger, César Piedra-Mora et al. · 2021 · JCI Insight
  94. The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy
    Yongmei Wang, Saisai Li, Wenqin Wang · 2024 · Frontiers in Immunology
  95. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy
    Nicholas S. Giacobbi, Shreya Mullapudi, Harrison Nabors, Dohun Pyeon · 2024 · Viruses
  96. Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases
    Christopher M. Fife, Jennifer M. Williams, Fiona James, Scott Gregory, Tereza Andreou, Ashley Sunderland, Clive S. McKimmie, Rebecca J. Brownlie, Robert J. Salmond, Samuel Heaton et al. · 2024 · Journal for ImmunoTherapy of Cancer
  97. The Ins and Outs of Chemokine-Mediated Immune Cell Trafficking in Skin Cancer
    Andrew On Wah Yam, Tatyana Chtanova · 2019 · Frontiers in Immunology
  98. Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
    Scott L. Baughan, Timothy D. Folsom, Matt Johnson, Joshua Kreuger, Beau R. Webber, Branden S. Moriarity · 2025 · Frontiers in Immunology
  99. Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma
    Emmanuel M Gabriel, Minhyung Kim, Daniel T. Fisher, Colin A. Powers, Kristopher M. Attwood, Sanjay Prakash Bagaria, Keith L. Knutson, Joseph J. Skitzki · 2020 · Scientific Reports
  100. A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
    Dechao Feng, Xu Shi, Qiao Xiong, Facai Zhang, Dengxiong Li, Lu Yang · 2022 · Frontiers in Oncology